Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Long-term benefits of induction therapy in NMO: a case report.
γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis.
Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod.
Effects of a resistance training program and subsequent detraining on muscle strength and muscle power in multiple sclerosis patients.
IL-17: A new actor in IFN-driven systemic autoimmune diseases.
Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery.
Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice.
Developing a therapeutic plan for treating MS: evidence for new treatments.
Neuromyelitis Optica Spectrum Disorder Associated with Cervical Spondylosis.
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.
The harm of ham hocks: Foreign body impaction in long-standing multiple sclerosis.
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.
Automatic Lesion Incidence Estimation and Detection in Multiple Sclerosis Using Multisequence Longitudinal MRI.
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.
Risk factors for multiple sclerosis: decreased vitamin D level and remote Epstein-Barr virus infection in the pre-clinical phase of multiple sclerosis.
Medical marijuana in neurology.
Psychosocial, Affective, and Behavioral Consequences of Multiple SclerosisTreatment of the "Whole" Patient.
Longitudinal association between depressive symptoms and walking impairment in people with relapsing-remitting multiple sclerosis.
[Retinal vasculitis as manifestation of multiple sclerosis.]
Effect of autoimmune diseases on risk and survival in female cancers.
Discovery of A-971432, an Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonists for the Potential Treatment of Neurodegenerative Disorders.
Correction: Correlation of Diffusion and Metabolic Alterations in Different Clinical Forms of Multiple Sclerosis.
Assessment of jugular endovascular malformations in chronic cerebrospinal venous insufficiency: colour-Doppler scanning and catheter venography compared with intravascular ultrasound.
Cognitive impairment is correlated with reduced quality of life in patients with clinically isolated syndrome.
Cognition and eye movements: assessment of cerebral dysfunction.

Pages